Perelman School of Medicine at the University of Pennsylvania

Goldberg Lab

Header Image

Ongoing Studies

THINKER: Transplanting Hepatitis C Kidneys Into Negative KidnEy Recipients

Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Kidney Transplants From Hepatitis C-Positive Donors (HCV)

  • This study is being conducted to determine safety and efficacy of transplanting kidneys from HCV virus (HCV)-positive donors into HCV-negative patients on the kidney transplant waitlist, who will then be treated with Zepatier status post-single kidney transplantation.
  • Why use HCV Positive Kidneys?
    • Patients usually wait at least 3-5 years for a kidney transplant. And while on dialysis, patients expereince a decrease in quality of life and woresening of their health.
    • With new medication available to treat Hepatitis C, there is the potential to expand the donor pool for patients saving hundreds of lives annually.
  • Learn more at